Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
5
×
national
national blog main
national top stories
new york blog main
new york top stories
novartis
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
drug prices
merck
pfizer
president trump
abbvie
alzheimer's disease
biogen
bristol-myers squibb
cancer
cancer immunotherapy
deals
What
drug
5
×
bio
roundup
companies
new
patients
pharmaceutical
plan
price
prices
today
acquisitions
advantages
albert
alzheimer’s
approval
away
bar
biggest
biogen’s
biopharmaceutical
bourla
bringing
brings
ceo
ceos
company
convo
crispr
dc
different
earlier
executives
expect
fail
failures
future
gamble
gathered
gene
Language
unknown
unset
Current search:
medicare
×
drug
×
novartis
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More